The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.

• Hauptverfasser: Myra Hardy (Verfasst von), Josaia Samuela (Verfasst von), Mike Kama (Verfasst von), Meciusela Tuicakau (Verfasst von), Lucia Romani (Verfasst von), Margot J Whitfeld (Verfasst von), Christopher L King (Verfasst von), Gary J Weil (Verfasst von), Anneke C Grobler (Verfasst von), Leanne J Robinson (Verfasst von), John M Kaldor (Verfasst von), Andrew C Steer (Verfasst von)
• Format: Buch
• Veröffentlicht: Public Library of Science (PLoS), 2020-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Lymphatic filariasis has remained endemic in Fiji despite repeated mass drug administration using the well-established and safe combination of diethylcarbamazine and albendazole (DA) since 2002. In certain settings the addition of ivermectin to this combination (IDA) remains a safe strategy and is m...